News & Updates

New drug applications approved by US FDA as of 1-15 September 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

In the closure of linear wounds of the trunk and extremities, running subcuticular (SQ) suturing technique is preferred by patients and evaluators alike over running horizontal mattress (HM) in terms of aesthetic outcome, reports a recent study.

In the treatment of severe recurrent aphthous stomatitis, roflumilast appears to reduce the number of flare-ups and ulcers, their duration, and ulcer-related symptoms, according to a study.

A novel handheld device can measure age-related skin parameters, including facial age, wrinkles, and skin evenness, with an accuracy that is similar to that of other well-established skin analysis devices, as reported in a study.

The use of a recombinant zoster vaccine (RZV) significantly lowers the risk of developing herpes zoster in older adults aged ≥65 years compared with placebo, according to a study presented at WONCA 2024.

In the treatment of psoriasis, selective inhibition of tyrosine kinase 2 (TYK2) with zasocitinib appears to have superior effects compared with placebo, with greater skin clearance observed over 12 weeks, according to data from a phase 2b study.

Several classes of commonly prescribed oral antibiotics appear to carry an increased risk of serious cutaneous adverse drug reactions (cADRs), according to a study.